News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
650,705 Results
Type
Article (48797)
Company Profile (252)
Press Release (601656)
Section
Business (189478)
Career Advice (2638)
Deals (34287)
Drug Delivery (111)
Drug Development (81419)
Employer Resources (162)
FDA (16639)
Job Trends (14191)
News (331152)
Policy (33685)
Tag
Academia (2519)
Alliances (46933)
Alzheimer's disease (1313)
Approvals (16546)
Artificial intelligence (143)
Bankruptcy (332)
Best Places to Work (10542)
Biotechnology (138)
Breast cancer (121)
Cancer (1101)
Cardiovascular disease (97)
Career advice (2196)
Cell therapy (249)
Clinical research (64633)
Collaboration (368)
Compensation (197)
COVID-19 (2644)
C-suite (98)
Data (1083)
Diabetes (161)
Diagnostics (5730)
Drug pricing (99)
Earnings (74653)
Employer resources (147)
Events (98092)
Executive appointments (290)
FDA (17161)
Funding (316)
Gene therapy (187)
GLP-1 (672)
Government (4169)
Healthcare (17003)
Infectious disease (2730)
Inflammatory bowel disease (112)
Interviews (476)
IPO (15785)
Job creations (4001)
Job search strategy (1855)
Layoffs (465)
Legal (8228)
Lung cancer (180)
Manufacturing (186)
Medical device (12203)
Medtech (12207)
Mergers & acquisitions (18562)
Metabolic disorders (457)
Neuroscience (1596)
NextGen Class of 2024 (5856)
Non-profit (3714)
Northern California (1401)
Obesity (266)
Opinion (232)
Patents (103)
People (54899)
Pharmaceutical (90)
Phase I (19814)
Phase II (28108)
Phase III (21783)
Pipeline (456)
Postmarket research (2794)
Preclinical (8220)
Radiopharmaceuticals (238)
Rare diseases (222)
Real estate (5738)
Regulatory (22656)
Research institute (2312)
Resumes & cover letters (438)
Southern California (1212)
Startups (3463)
United States (12731)
Vaccines (634)
Weight loss (219)
Date
Today (178)
Last 7 days (958)
Last 30 days (3631)
Last 365 days (35239)
2024 (31997)
2023 (39130)
2022 (50081)
2021 (54093)
2020 (51697)
2019 (42876)
2018 (32750)
2017 (32517)
2016 (31563)
2015 (35660)
2014 (29174)
2013 (24460)
2012 (26480)
2011 (27240)
2010 (25334)
Location
Africa (808)
Arizona (162)
Asia (40505)
Australia (6494)
California (3099)
Canada (1175)
China (244)
Colorado (139)
Connecticut (157)
Europe (91248)
Florida (426)
Georgia (114)
Illinois (309)
Indiana (191)
Maryland (567)
Massachusetts (2525)
Michigan (133)
Minnesota (240)
New Jersey (917)
New York (894)
North Carolina (730)
Northern California (1401)
Ohio (120)
Pennsylvania (780)
South America (1201)
Southern California (1212)
Texas (429)
Washington State (344)
650,705 Results for "covis pharma holdings s a r l".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Agile Therapeutics Inc. Announces Definitive Merger Agreement with Insud Pharma, S.L.
Agile Therapeutics, Inc. today announced that it has entered into a definitive merger agreement (“Merger Agreement”) with Insud Pharma, S.L.
June 26, 2024
·
10 min read
Editorial
Pharma’s Q3 Was a Rollercoaster Ride. Let’s Do It Again Next Quarter
Big Pharma had plenty of drama to keep journalists busy this quarter, which painted an accurate portrait of the wild and wonderful world of biopharma.
November 15, 2024
·
3 min read
·
Annalee Armstrong
Press Releases
Nxera Pharma’s Partner Centessa Initiates Phase 2 Trial with ORX750, a Novel Orexin Receptor 2 (OX2R) Agonist
November 12, 2024
·
4 min read
Business
Agile Therapeutics Inc. Announces Completion of Acquisition by Insud Pharma, S.L.
August 26, 2024
·
5 min read
Deals
Frontage Laboratories Acquires Accelera S.r.l.'s Bioanalytical and DMPK Businesses
Frontage Laboratories, Inc. today announced that, through its wholly-owned subsidiary Frontage Europe S.r.l., it has completed the acquisition of the Bioanalytical and Drug Metabolism & Pharmacokinetics businesses of Accelera S.r.l (Accelera).
January 2, 2024
·
5 min read
Press Releases
HOOKIPA Pharma’s Eseba-vec Highlighted in SITC Late-Breaker
November 12, 2024
·
6 min read
Press Releases
LEO Pharma’s Anzupgo® (delgocitinib) Cream Achieves Marketing Approval in Switzerland
November 14, 2024
·
11 min read
MASH
Boston Pharma Carves Out Monthly Treatment Niche in MASH With Strong Phase II Data
Boston Pharma’s once-monthly injection efimosfermin alfa offers a convenient dosing option for MASH patients while also achieving promising rates of fibrosis and MASH improvement, according to a Phase II readout.
November 18, 2024
·
2 min read
·
Tristan Manalac
Cell and gene therapy
Big Pharma’s Interest Grows in Evolving Cell and Gene Therapy Sector
Large pharmaceutical companies were out in force at this week’s 2024 Cell & Gene Meeting on the Mesa, as they look to expand their presence in the industry.
October 9, 2024
·
4 min read
·
Greg Slabodkin
Press Releases
Nxera Pharma to Host R&D Day 2024
October 18, 2024
·
2 min read
1 of 65,071
Next
